Text Size
411 studies found for:    Open Studies | "Arthritis, Rheumatoid"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting The Predictive Value of Ultrasound in Early Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Predictive Value of Ultrasound in Early Rheumatoid Arthritis
Intervention:
2 Recruiting An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis
Conditions: Arthritis;   Arthritis, Rheumatoid;   Joint Diseases;   Musculoskeletal Diseases;   Rheumatic Diseases;   Connective Tissue Diseases;   Autoimmune Diseases
Interventions: Procedure: Magnetic resonance imaging (MRI);   Other: Conventional biochemical and clinical examinations
3 Not yet recruiting Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Neovascularization, Pathologic;   Synovitis
Intervention:
4 Recruiting Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: Milnacipran
5 Unknown † Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Vitamin D Deficiency
Interventions: Drug: Placebo in arm A and Vitamin D in arm B;   Drug: vitamin D 3 for arm A ,and matching placebo for arm B
6 Recruiting A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: Sirukumab;   Drug: Midazolam;   Drug: Warfarin;   Drug: Vitamin K;   Drug: Omeprazole;   Drug: Caffeine
7 Recruiting A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab;   Drug: Methotrexate
8 Recruiting A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K;   Drug: Placebo
9 Recruiting A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects
Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K;   Drug: Placebo
10 Recruiting A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate
Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K;   Drug: Placebo
11 Recruiting A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo + methotrexate (MTX) (Group 1);   Drug: Ustekinumab + MTX (Group 2);   Drug: Ustekinumab + MTX (Group 3);   Drug: CNTO 1959 + MTX (Group 4);   Drug: CNTO 1959 + MTX (Group 5)
12 Recruiting A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
Condition: Arthritis, Rheumatoid
Interventions: Drug: Sirukumab 100 mg;   Drug: Sirukumab 50 mg;   Drug: Placebo
13 Recruiting A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Drug: Sirukumab
14 Recruiting A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Drug: Sirukumab
15 Recruiting Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP-690,550
16 Recruiting Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: PRTX-100 at 1.5 mcg/kg;   Drug: PRTX-100 at 3.0 mcg/kg;   Drug: PRTX-100 at 6.0 mcg/kg;   Drug: PRTX-100 at 12.0 mcg/kg;   Drug: PRTX-100 at 18.0 mcg/kg;   Drug: Placebo
17 Recruiting Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: BI 695500;   Drug: rituximab
18 Unknown † Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes
Conditions: Fatigue Syndrome, Chronic;   Fibromyalgia;   Arthritis, Rheumatoid
Interventions: Drug: citalopram;   Drug: 1 ml 0.9 % NaCl
19 Recruiting A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.
Condition: Arthritis, Rheumatoid
Intervention: Other: Questionnaire
20 Unknown † Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing
Intervention: Drug: TNF blockers (infliximab, adalimumab, etanercept)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years